James J. Burns & Company LLC Has $298,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

James J. Burns & Company LLC grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,051 shares of the financial services provider’s stock after buying an additional 347 shares during the period. James J. Burns & Company LLC’s holdings in iShares Biotechnology ETF were worth $298,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Fin Capital Inc. lifted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the period. Security National Bank of SO Dak lifted its stake in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after acquiring an additional 75 shares during the period. SPC Financial Inc. lifted its stake in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management grew its holdings in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC raised its stake in iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.0 %

Shares of NASDAQ IBB opened at $142.85 on Tuesday. iShares Biotechnology ETF has a 1 year low of $113.56 and a 1 year high of $150.57. The company has a 50-day moving average price of $145.02 and a 200-day moving average price of $140.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.